Rubicon Research IPO: A Game-Changer for Indian Pharmaceutical Industry
Rubicon Research Ltd., backed by US private equity giant General Atlantic, is set to launch its Rs 1,377.5-crore initial public offering of shares. Here’s what you need to know about this highly anticipated IPO.